Critical role for macrophage migration inhibitory factor (MIF) in Ross River virus-induced arthritis and myositis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 29, 2011, Pages 12048-12053

  Herrero, Lara J ^a,b   Nelson, Michelle ^a   Srikiatkhachorn, Anon ^c   Gu, Ran ^d   Anantapreecha, Surapee ^e   Fingerle Rowson, Gun̈ter ^f   Bucala, Richard ^g   Morand, Eric ^d   Santos, Leilani L ^d   Mahalingam, Suresh ^a,b  

^a UNIVERSITY OF CANBERRA   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d MONASH UNIVERSITY   (Australia)

^e MINISTRY OF PUBLIC HEALTH   (Thailand)

^f UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^g YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Immunology; Migration inhibitory factor antagonist; Proinflammatory cytokine; Therapeutics; Viral arthritis

Indexed keywords

CYTOKINE RECEPTOR ANTAGONIST; MACROPHAGE MIGRATION INHIBITION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; INFLAMMATORY INFILTRATE; MOUSE; MYOSITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ROSS RIVER ALPHA VIRUS; TISSUE INJURY; VIRUS LOAD;

ANALYSIS OF VARIANCE; ANIMALS; ARTHRITIS; CHEMOKINE CCL2; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HISTOLOGICAL TECHNIQUES; INTERFERON-GAMMA; INTRAMOLECULAR OXIDOREDUCTASES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOSITIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ROSS RIVER VIRUS;

ALPHAVIRUS; MUS; O'NYONG-NYONG VIRUS; ROSS RIVER VIRUS;

EID: 79961074110     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1101089108     Document Type: Article

References (50)

1. Suhrbier A, La Linn M (2004) Clinical and pathologic aspects of arthritis due to Ross River virus and other alphaviruses. Curr Opin Rheumatol 16:374-379. (Pubitemid 38803138)
2. Rulli NE, Melton J, Wilmes A, Ewart G, Mahalingam S (2007) The molecular and cellular aspects of arthritis due to alphavirus infections: Lesson learned from Ross River virus. Ann N Y Acad Sci 1102:96-108. (Pubitemid 47084912)
3. Suhrbier A, Mahalingam S (2009) The immunobiology of viral arthritides. Pharmacol Ther 124:301-308.
4. Harley D, Sleigh A, Ritchie S (2001) Ross River virus transmission, infection, and disease: A cross-disciplinary review. Clin Microbiol Rev 14:909-932. (Pubitemid 32979635)
5. Renault P, et al. (2007) A major epidemic of Chikungunya virus infection on Reunion Island, France, 2005-2006. Am J Trop Med Hyg 77:727-731. (Pubitemid 351844300)
6. Josseran L, et al. (2006) Chikungunya disease outbreak, Reunion Island. Emerg Infect Dis 12:1994-1995. (Pubitemid 44904950)
7. Kalantri SP, Joshi R, Riley LW (2006) Chikungunya epidemic: An Indian perspective. Natl Med J India 19:315-322.
8. Yergolkar PN, et al. (2006) Chikungunya outbreaks caused by African genotype, India. Emerg Infect Dis 12:1580-1583. (Pubitemid 44570904)
9. Thavara U, et al. (2009) Outbreak of Chikungunya fever in Thailand and virus detection in field population of vector mosquitoes, Aedes aegypti (L.) and Aedes albopictus Skuse (Diptera: Culicidae). Southeast Asian J Trop Med Public Health 40: 951-962.
10. Theamboonlers A, Rianthavorn P, Praianantathavorn K, Wuttirattanakowit N, Poovorawan Y (2009) Clinical and molecular characterization of Chikungunya virus in South Thailand. Jpn J Infect Dis 62:303-305.
11. Sam IC, et al. (2009) Chikungunya virus of Asian and Central/East African genotypes in Malaysia. J Clin Virol 46:180-183.
12. Liumbruno GM, et al. (2008) The Chikungunya epidemic in Italy and its repercussion on the blood system. Blood Transfus 6:199-210.
13. Old JM, Deane EM (2005) Antibodies to the Ross River virus in captive marsupials in urban areas of eastern New South Wales, Australia. J Wildl Dis 41:611-614. (Pubitemid 41622867)
14. Fraser JR (1986) Epidemic polyarthritis and Ross River virus disease. Clin Rheum Dis 12: 369-388.
15. Harley D, Bossingham D, Purdie DM, Pandeya N, Sleigh AC (2002) Ross River virus disease in tropical Queensland: Evolution of rheumatic manifestations in an inception cohort followed for six months. Med J Aust 177:352-355. (Pubitemid 36104279)
16. Mylonas AD, et al. (2002) Natural history of Ross River virus-induced epidemic polyarthritis. Med J Aust 177:356-360. (Pubitemid 36104280)
17. Lidbury BA, Simeonovic C, Maxwell GE, Marshall ID, Hapel AJ (2000) Macrophage-induced muscle pathology results in morbidity and mortality for Ross River virusinfected mice. J Infect Dis 181:27-34. (Pubitemid 30049029)
18. Lidbury BA, et al. (2008) Macrophage-derived proinflammatory factors contribute to the development of arthritis and myositis after infection with an arthrogenic alphavirus. J Infect Dis 197:1585-1593. (Pubitemid 351706489)
19. Morrison TE, Fraser RJ, Smith PN, Mahalingam S, Heise MT (2007) Complement contributes to inflammatory tissue destruction in a mouse model of Ross River virus-induced disease. J Virol 81:5132-5143. (Pubitemid 46744424)
20. Morrison TE, et al. (2006) Characterization of Ross River virus tropism and virus-induced inflammation in a mouse model of viral arthritis and myositis. J Virol 80: 737-749. (Pubitemid 43062886)
21. Rulli NE, et al. (2009) Amelioration of alphavirus-induced arthritis and myositis in a mouse model by treatment with bindarit, an inhibitor of monocyte chemotactic proteins. Arthritis Rheum 60:2513-2523.
22. Gregory JL, et al. (2006) Macrophage migration inhibitory factor induces macrophage recruitment via CC chemokine ligand 2. J Immunol 177:8072-8079. (Pubitemid 44846325)
23. Santos LL, Morand EF (2006) The role of macrophage migration inhibitory factor in the inflammatory immune response and rheumatoid arthritis. Wien Med Wochenschr 156:11-18. (Pubitemid 43235476)
24. Santos LL, Morand EF (2009) Macrophage migration inhibitory factor: A key cytokine in RA, SLE and atherosclerosis. Clin Chim Acta 399:1-7.
25. Leech M, et al. (1999) Macrophage migration inhibitory factor in rheumatoid arthritis: Evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum 42:1601-1608. (Pubitemid 30263626)
26. Onodera S, et al. (1999) High expression of macrophage migration inhibitory factor in the synovial tissues of rheumatoid joints. Cytokine 11:163-167. (Pubitemid 29116556)
27. Leech M, et al. (2003) Regulation of p53 by macrophage migration inhibitory factor in inflammatory arthritis. Arthritis Rheum 48:1881-1889. (Pubitemid 36828683)
28. Santos L, Hall P, Metz C, Bucala R, Morand EF (2001) Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis: Interaction with glucocorticoids. Clin Exp Immunol 123:309-314. (Pubitemid 32174784)
29. Chen LC, et al. (2006) Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in Dengue patients. Am J Trop Med Hyg 74:142-147.
30. Arjona A, et al. (2007) Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion. J Clin Invest 117: 3059-3066. (Pubitemid 47529635)
31. Morand EF, Leech M (2005) Macrophage migration inhibitory factor in rheumatoid arthritis. Front Biosci 10:12-22. (Pubitemid 40543012)
32. Calandra T, Roger T (2003) Macrophage migration inhibitory factor: A regulator of innate immunity. Nat Rev Immunol 3:791-800. (Pubitemid 37328657)
33. Falgarone G, Jaen O, Boissier MC (2005) Role for innate immunity in rheumatoid arthritis. Joint Bone Spine 72:17-25. (Pubitemid 40169959)
34. Ayoub S, Hickey MJ, Morand EF (2008) Mechanisms of disease: Macrophage migration inhibitory factor in SLE, RA and atherosclerosis. Nat Clin Pract Rheumatol 4:98-105. (Pubitemid 351217659)
35. Morand EF, Leech M, Bernhagen J (2006) MIF: A new cytokine link between rheumatoid arthritis and atherosclerosis. Nat Rev Drug Discov 5:399-410.
36. Mikulowska A, Metz CN, Bucala R, Holmdahl R (1997) Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice. J Immunol 158:5514-5517. (Pubitemid 127681261)
37. Leech M, et al. (1998) Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis. Arthritis Rheum 41:910-917. (Pubitemid 28225792)
38. Rollins BJ (1997) Chemokines. Blood 90:909-928.
39. Cheng Q, et al. (2010) Macrophage migration inhibitory factor increases leukocyte-endothelial interactions in human endothelial cells via promotion of expression of adhesion molecules. J Immunol 185:1238-1247.
40. Calandra T, Bernhagen J, Mitchell RA, Bucala R (1994) The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 179:1895-1902. (Pubitemid 24155670)
41. Calandra T, Bucala R (1997) Macrophage migration inhibitory factor (MIF): A glucocorticoid counter-regulator within the immune system. Crit Rev Immunol 17:77-88. (Pubitemid 27068808)
42. Bacher M, Eickmann M, Schrader J, Gemsa D, Heiske A (2002) Human cytomegalovirus-mediated induction of MIF in fibroblasts. Virology 299:32-37. (Pubitemid 35007508)
43. Arndt U, et al. (2002) Release of macrophage migration inhibitory factor and CXCL8/ interleukin-8 from lung epithelial cells rendered necrotic by influenza A virus infection. J Virol 76:9298-9306. (Pubitemid 34919888)
44. Assunção-Miranda I, Bozza MT, Da Poian AT (2010) Pro-inflammatory response resulting from Sindbis virus infection of human macrophages: Implications for the pathogenesis of viral arthritis. J Med Virol 82:164-174.
45. Suzuki T, et al. (2000) Japanese encephalitis virus up-regulates expression of macrophage migration inhibitory factor (MIF) mRNA in the mouse brain. Biochim Biophys Acta 1517:100-106.
46. Assunção-Miranda I, et al. (2010) Contribution of macrophage migration inhibitory factor to the pathogenesis of Dengue virus infection. FASEB J 24:218-228.
47. Morand EF (2005) New therapeutic target in inflammatory disease: Macrophage migration inhibitory factor. Intern Med J 35:419-426.
48. Calandra T, et al. (1995) MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377:68-71.
49. Kuhn RJ, Niesters HG, Hong Z, Strauss JH (1991) Infectious RNA transcripts from Ross River virus cDNA clones and the construction and characterization of defined chimeras with Sindbis virus. Virology 182:430-441.
50. Fingerle-Rowson G, et al. (2003) The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting. Proc Natl Acad Sci USA 100:9354-9359. (Pubitemid 37033932)